Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

West Pharmaceutical Servs Raises FY2025 Adj EPS Guidance from $6.65-$6.85 to $7.06-$7.11 vs $6.77 Est; Raises FY2025 Sales Guidance from $3.040B-$3.060B to $3.060B-$3.070B vs $3.050B Est

Author: Benzinga Newsdesk | October 23, 2025 06:02am
West Pharmaceutical Servs (NYSE:WST) raises FY2025 Adj EPS guidance from $6.65-$6.85 to $7.06-$7.11 vs $6.77 analyst estimate. Raises FY2025 sales outlook from $3.040 billion-$3.060 billion to $3.060 billion-$3.070 billion vs $3.050 billion estimate.

Posted In: WST


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist